Strides Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA686112
EBIT523-365
Earning Per Share28-51
Expenses2,6893,090
Net Profit356-363
Net Profit Margin10-12
Operating Profit Margin214
Profit Before Tax373-542
Dividends Per Share30
Operation Revenue3,3753,202

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
20221,739.202,486.90993.609,042.131,441.20
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Strides Pharma is 112 as of 2/28/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20112011201120112014
Operating Activities457457457457-272
Investing Activities-656-656-656-6564,077
Financing Activities89898989-3,319
Others00000
Net Cash Flow-110-110-110-110487

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2021-2.18-34.87-15.36-52.41
2023625.39-528.49-77.4619.45
20201,468.841,106.99-890.581,685.25
20235,887.50-4,137.30-2,686.10-935.90
20234,959.33-7,943.682,376.07-608.28
The cash flow from Operating Activities of Strides Pharma is -272 as of 2/28/2024